Use of Digital Whole Slide Imaging in Dermatopathology

Tracy Onega1,2, Lisa M Reisch3, Paul D Frederick3

  • 1Department of Biomedical Data Science, Department of Epidemiology, Norris Cotton Cancer Center, Lebanon, NH, USA. Tracy.L.Onega@dartmouth.edu.

Insights

Most pathologists do not use digital whole slide imaging (WSI) for melanocytic lesions, but those who do use it for education. While accurate diagnoses are possible, speed remains a concern for routine clinical use.

Area of Science:

  • Digital pathology and medical imaging
  • Dermatopathology and diagnostic technology
  • Pathology practice patterns and adoption

Background:

  • Digital whole slide imaging (WSI) presents unique challenges for dermatopathology.
  • Little is known about current pathologist practices and perceptions of WSI for melanocytic lesions.

Purpose of the Study:

  • To investigate practice patterns and perceptions of WSI among pathologists interpreting melanocytic lesions.
  • To understand the current use cases and barriers to WSI adoption in dermatopathology.

Main Methods:

  • A national cross-sectional survey of 207 pathologists from ten US states.
  • Survey questions covered experience, practice patterns, and perceptions of WSI using a 6-point Likert scale.

Main Results:

  • 41% of pathologists reported WSI experience, primarily for education (71%) and tumor boards (44%).
  • 77% agreed accurate diagnoses are possible with WSI, and 59% saw benefits outweighing concerns.
  • 78% found WSI too slow for routine interpretation; adoption interest was split (49% yes, 51% no).

Conclusions:

  • The majority of pathologists interpreting melanocytic lesions do not currently use WSI.
  • Perceptions are mixed, with concerns about speed for routine use, despite agreement on diagnostic accuracy.
  • Understanding current practices is crucial for facilitating future WSI adoption in dermatopathology.